BIPOLAR DEPRESSION
Clinical trials for BIPOLAR DEPRESSION explained in plain language.
Never miss a new study
Get alerted when new BIPOLAR DEPRESSION trials appear
Sign up with your email to follow new studies for BIPOLAR DEPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Ketamine infusions show promise for tough-to-treat bipolar depression
Disease control CompletedThis study looked at whether repeated ketamine infusions can help people with bipolar depression who did not get better with other treatments. 41 adults who already responded to an initial course of ketamine received up to 6 more infusions over 12 weeks. The goal was to see if th…
Matched conditions: BIPOLAR DEPRESSION
Phase: PHASE2 • Sponsor: Joshua Rosenblat • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
Immune booster shows promise for bipolar depression
Symptom relief CompletedThis small study tested whether low-dose interleukin-2 (IL-2) could help people with bipolar disorder who are currently depressed. Fourteen participants already on mood stabilizers received the drug to see if it would improve their immune system's regulatory cells and ease depres…
Matched conditions: BIPOLAR DEPRESSION
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated May 26, 2026 05:53 UTC
-
Sound waves for the mind: can ultrasound tame anxiety and depression?
Symptom relief CompletedThis study tested a new, non-invasive treatment for people with depression, anxiety, bipolar disorder, or PTSD. Researchers used low-intensity focused ultrasound to gently stimulate a brain region called the amygdala over 15 sessions. The goal was to see if this approach is safe …
Matched conditions: BIPOLAR DEPRESSION
Phase: NA • Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated May 26, 2026 05:53 UTC
-
Could a fatty acid ease bipolar depression?
Symptom relief CompletedThis study tested whether a natural compound called palmitoylethanolamide (PEA) can help reduce depression in people with bipolar disorder. 34 adults who were already taking a mood stabilizer took PEA or a placebo. Researchers measured changes in depression scores and looked for …
Matched conditions: BIPOLAR DEPRESSION
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated May 26, 2026 05:49 UTC
-
New pill shows promise for lifting bipolar depression
Symptom relief CompletedThis study tested a new medication called ITI-007 (Lumateperone) to see if it can safely ease depression in people with bipolar I or II disorder. About 550 adults experiencing a major depressive episode took either the drug or a placebo for 6 weeks. The main goal was to measure c…
Matched conditions: BIPOLAR DEPRESSION
Phase: PHASE3 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Symptom relief
Last updated May 26, 2026 05:47 UTC
-
Ketamine shows promise for bipolar depression in new trial
Symptom relief CompletedThis study tested whether repeated doses of intravenous ketamine can safely and effectively reduce depression in people with bipolar disorder who haven't responded to other treatments. 71 adults with bipolar I or II and current major depression received four ketamine infusions or…
Matched conditions: BIPOLAR DEPRESSION
Phase: PHASE2 • Sponsor: Joshua Rosenblat • Aim: Symptom relief
Last updated May 26, 2026 05:44 UTC
-
Ketamine's brain impact revealed in bipolar depression study
Knowledge-focused CompletedThis study looked at how ketamine changes brain connections in people with bipolar depression that hasn't improved with other treatments. Twenty adults received ketamine and had brain scans before and after. The goal was to see if brain activity patterns could predict who gets be…
Matched conditions: BIPOLAR DEPRESSION
Phase: PHASE2 • Sponsor: Brian Barnett • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC